awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q43405471-294D3063-B6D4-453F-8787-510C09A58C59
Q43405471-294D3063-B6D4-453F-8787-510C09A58C59
BestRank
Statement
http://www.wikidata.org/entity/statement/Q43405471-294D3063-B6D4-453F-8787-510C09A58C59
A phase II multicenter study of visilizumab, humanized anti-CD3 antibody, to treat steroid-refractory acute graft-versus-host disease.
P698
Q43405471-294D3063-B6D4-453F-8787-510C09A58C59
BestRank
Statement
http://www.wikidata.org/entity/statement/Q43405471-294D3063-B6D4-453F-8787-510C09A58C59
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
647042e035820c59d06cea7ab864a444f9e60c83
P698
15931635
http://www.w3.org/2001/XMLSchema#string